The xc− cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance
Maisie Lo(University of British Columbia), Peter W. Gout(BC Cancer Agency)
Cited by 229
Related Papers
Patient-Derived First Generation Xenografts of Non–Small Cell Lung Cancers: Promising Tools for Predicting Drug Responses for Personalized Chemotherapy
|Clinical Cancer Research|2010|195
The x c − cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine
|Cancer Chemotherapy and Pharmacology|2008|131
Establishment in Severe Combined Immunodeficiency Mice of Subrenal Capsule Xenografts and Transplantable Tumor Lines from a Variety of Primary Human Lung Cancers: Potential Models for Studying Tumor Progression–Related Changes
|Clinical Cancer Research|2006|107
Role of transporters in pancreatic cancer drug resistance
|cIRcle (University of British Columbia)|2008|0